Gerresheimer is a Manufacturer/Innovator, Contract Service company operating in the pharmaceutical industry.
Gerresheimer is the innovative system and solution provider and global partner for the pharma, biotech and cosmetic industry. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, infusion, dropper and syrup bottles, and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient.. With 36 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets. With over 11,000 employees, the company generated revenues of around ?1.82bn in 2022. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
Company type
Manufacturer/Innovator, Contract Service
Products and services
Biopharmaceuticals, Custom Manufacturing, Pharmaceutical Packaging, Contract Services – Analytical & Lab Services, Laboratory and Analytical Equipment, Pharmaceutical Machinery & Technology
Markets
North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Visit the Gerresheimer Website
Connect with Gerresheimer on Facebook
Connect with Gerresheimer on LinkedIn
Address
Gerresheimer, Klaus-Bungert-StraSSe 4, Duesseldorf, Germany, 40468